ABSTRACT: Foster care children who engage in challenging behavior are likely to receive psychotropic medication as the primary intervention to reduce their behavior. These children are more likely to receive multiple psychotropic medications from the same class or three or more medications to treat a given behavioral condition, a practice called polypharmacy. In response to this practice, federal legislation mandated states to monitor psychotropic medication prescriptions to foster care children. Consequently, the Deputy Director of the Alabama Department of Human Resources proposed the development of a behavioral health professional team, collectively known as the Alabama Psychiatric Medication Review Team (APMRT). The APMRT was tasked with developing application and safety guidelines for prescribers and determining the extent to which behavioral interventions are a cost-effective alternative for managing problem behavior. This paper briefly outlines APMRT's general strategies, describes the team members' roles, and discusses future directions.
Due to familial trauma, abuse, and neglect, over 400,000 youth in 2016 were placed in foster care in the U.S. (United States Department of Health and Human Services, 2017) . When compared to children who reside with their biological parents, foster children are more likely to display disruptive behavior (Bronsard et al., 2016) and to be prescribed psychotropic medications to treat their behavior problems (Zima, Bussing, Crecelius, Kaufman, & Belin, 1999; United States Government Accounting Office, 2012) . Although estimates range geographically and placement (community-based foster care, therapeutic foster home, or group homes), studies suggest 13 -40% of foster youth receive one or more psychotropic medications in community settings (Leslie, Raghavan, Zhang, & Aarons, 2010; Raghavan & McMillen, 2008; Raghavan, Brown, Allaire, Garfield, & Ross, 2014) . In general, foster care children are more likely to receive (a) multiple medications concurrently to treat a single condition, (b) dosages of one or more psychotropic medications that exceed maximum recommended values, or (c) off-label application of medication (Harrison, Cluxton-Keller, & Gross, 2012; Steel & Buchi, 2008; Zito et al., 2008) . Although various social variables have likely contributed to the conditions that gave rise to (a), (b), and (c), researchers have speculated time pressures on foster care parents and prescribers may account for the recent explosion in psychotropic prescriptions for foster care youth (Alavi & Calleja, 2012) . Additionally, Harrison et al. (2012) noted the failure to provide alternative, non-pharmacological, treatment also stems from a shortage of professionals who provide such treatment.
In response to this emerging crisis within the foster-care system, the Child and Family Services Improvement and Innovation Act (2011) mandated states to develop systems to monitor psychotropic medication usage. States were required to create oversight systems for prescribing practices. Pursuant to this legislation, the Deputy Director of Alabama Department of Human Resources proposed the development of the Alabama Psychiatric Medication Review Team (APMRT) and obtained funding for a contract with the Applied Behavior Analysis program in the Department of Psychology at Auburn University. The Deputy Director tasked the second and third authors with populating the APMRT. We aim to outline APMRT's strategies, possible barriers to those strategies, and future directions for reducing reliance on psychotropic medication for treating behavior problems displayed by foster youth.
Strategies
Prior to statewide implementation of policy changes, the APMRT is piloting three broad strategies, each with distinct independent and dependent variables. Initially, the project began with seven counties in East Alabama including rural, small municipal, and urban communities. Plans are underway to expand into an urban setting, Jefferson County, which includes much of Birmingham. Some strategies are implemented at an individual level whereas others are designed for systems level implementation. APMRT actions can be conceptualized as antecedent interventions, consequent interventions, and both.
First, APMRT is piloting tactics to reduce the numbers and doses of psychotropic medications by providing expert consultation to specific prescribers. Presumably, these prescribers (psychiatrists, nurse practitioners, pediatricians, and family practice physicians) have varying levels of expertise with foster care youth and psychotropic medications. Consultations are initiated by either (a) application of red flag criteria 2 or (b) concerns raised during BCBA direct observations of foster youth. The written consultations, addressed to the prescriber for a specific child, include evidence-based standards for minimum and maximum dosages, age appropriate medication use, drug-drug interactions, previously undetected medication side-effects, and recommendations on the use of as needed dosing. Providing written consultation aims to standardize prescribing practices and increase awareness of the concern of over-prescription of psychotropic medications to children in foster care. To date, this approach constitutes an antecedent intervention insofar as compliance with APMRT recommendations is not enforced.
Second, APMRT members have conducted in-situ training sessions for case workers and foster parents. These training sessions (a) review information for case workers and foster parents about the APMRT's role in psychotropic and behavioral interventions for foster care children and (b) provide instructions for case workers and foster parents to make formal referrals for behavioral and medication services. We have also created online training modules for prescribers and foster parents that detail guidelines regarding best prescribing practices ("red flag" criteria and "black box" warning descriptions) and strategies to help foster-parents work confidently and assertively with prescribers in making data-based decisions during appointments. APMRT is also using databases to describe filled prescriptions to characterize prescribing practices, identify prescribers who work frequently with foster children, and to identify children who might be experiencing excessive psychotropic medication. This broad strategy includes numerous antecedent and consequent interventions, implemented at individual and systems levels.
The final strategy we employ is a preventive one in which we encourage foster care parents and caseworkers to use behavioral interventions as the primary treatment for problem behavior. As a step toward this goal, we solicit referrals for foster children who display problem behavior but have not yet received psychotropic medication. In so doing, we successfully treated some foster youth with standard behavioral interventions (e.g., token systems, three-step guided compliance, and planned ignoring), precluding the difficulties associated with changing prescriber behavior.
Team Members
The APMRT currently comprises 10 members. Table 1 identifies different foster-care system entities and outlines team member's contributions to decrease psychotropic medication reliance for each change agent. The entire team meets weekly to review current cases, update progress on prescriber protocols, discuss challenges from change agents, develop solutions, and outline next steps.
Future Directions
Contingent on state funding, the APMRT will continue to monitor prescribing practices for Alabama's foster care youth in the selected catchment, with the possibility of expanding in future years. The APMRT is conducting an analysis of the relative costs (and potential savings) of replacing psychotropic medication with behavioral interventions. Subsequently, the APMRT will deliver training on the new psychotropic medication guidelines statewide in early 2019. We will be asking county staff, foster parents, residential treatment providers, mental health providers and prescribing physicians to participate in various training events. Following the training, the APMRT will examine prescriber adherence to recommended practices.
To date, the APRMT has seen varying levels of progress with each targeted entity. Though we have spent our first year gathering data and working with prescribers on a small scale, we anticipate broader actions in the second year of the project. In addition, caseworkers have informed us that BCBA-designed behavioral interventions have produced notable successes for children on their caseloads, while others appear cautious about APMRT. Parent groups have been especially enthusiastic and have informed other foster parents, who are outside of our network, of our services using word-of-mouth and social networking. Foster parents have voiced their strong support for the training we provide. Specifically, parents noted they could not have kept their foster child without our services. One foster parent has actually initiated the process of adoption of a child that 
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they had nearly returned to the system because of aggression. Teachers have also expressed interest in working with BCBAs to develop programming for foster children when in school. We look forward to publishing our preliminary findings on the behavior of both prescribers and foster children in the near future.
